Ligand Pharmaceuticals Incorporated (LGND)
NASDAQ: LGND · Real-Time Price · USD
288.74
-3.03 (-1.04%)
Aug 18, 2026, 9:57 AM EDT - Market open
Ligand Pharmaceuticals Employees
Ligand Pharmaceuticals had 47 employees as of December 31, 2025. The number of employees decreased by 21 or -30.88% compared to the previous year.
Employees
47
Change (1Y)
-21
Growth (1Y)
-30.88%
Revenue / Employee
$6,181,745
Profits / Employee
$4,196,170
Market Cap
5.76B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 47 | -21 | -30.88% |
| Dec 31, 2024 | 68 | 10 | 17.24% |
| Dec 31, 2023 | 58 | -18 | -23.68% |
| Dec 31, 2022 | 76 | -78 | -50.65% |
| Dec 31, 2021 | 154 | -1 | -0.65% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Caris Life Sciences | 1,846 |
| PTC Therapeutics | 991 |
| Travere Therapeutics | 497 |
| Mirum Pharmaceuticals | 433 |
| CRISPR Therapeutics AG | 393 |
| Xenon Pharmaceuticals | 370 |
| Scholar Rock Holding | 289 |
| Definium Therapeutics | 106 |
LGND News
- 1 day ago - Ligand price target raised to $390 from $387 at Citi - TheFly
- 2 days ago - Ligand initiated with an Outperform at Leerink - TheFly
- 11 days ago - Ligand price target raised to $345 from $340 at RBC Capital - TheFly
- 11 days ago - Ligand price target raised to $358 from $289 at H.C. Wainwright - TheFly
- 12 days ago - Ligand Pharmaceuticals Earnings Call Transcript: Q2 2026 - Transcripts
- 12 days ago - Ligand Pharmaceuticals Earnings release: Q2 2026 - Filings
- 12 days ago - Ligand Pharmaceuticals Slides: Q2 2026 - Filings
- 12 days ago - Ligand Pharmaceuticals Quarterly report: Q2 2026 - Filings